Research
Hormonal
Tirzepatid (GIP/GLP-1 agonist) provides superior weight loss and glycemic control compared to Semaglutid in patients with Type 2 Diabetes and Obesity.
If oral medications and lifestyle changes are insufficient, Tirzepatid (10-15mg weekly) is currently the most effective pharmacological option for weight loss and blood sugar control in Type 2 Diabetes, outperforming Semaglutid. Discuss this with your doctor to see if it's appropriate for your specific health profile.
StrongSupportsVERY_HIGH confidence
Letztlich konnte für 10 mg bzw. 15 mg Tirzepatid eine klare Überlegenheit im Vergleich zu Semaglutid sowohl hinsichtlich HbA1c (p = 0,002) als auch Gewichtsreduktion (p < 0,001) gezeigt werden [46].
Why this rating
Based on SURPASS 2, a high-quality phase 3 RCT.
Source
Adipositas und Diabetes mellitus Typ 2 (Update 2026)
Johanna M. Brix et al. · Wiener klinische Wochenschrift · 2026
DOI 10.1007/s00508-026-02706-y
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Metabolic (bariatric) surgery is indicated for Type 2 Diabetes patients with BMI > 30 kg/m2 and can lead to significant diabetes remission.Strong
- Intensive lifestyle intervention leading to significant weight loss (≥15 kg) can induce remission of type 2 diabetes in patients with short disease duration (<6 years).Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →